NAMI vs BMBL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 17, 2026

NAMI

39.8
AI Score
VS
NAMI Wins

BMBL

38.4
AI Score

Investment Advisor Scores

NAMI

40score
Recommendation
AVOID NEW MONEY

BMBL

38score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric NAMI BMBL Winner
Forward P/E 0 9.3197 Tie
PEG Ratio 0 0 Tie
Revenue Growth -31.9% -15.2% BMBL
Earnings Growth 0.0% 169.8% BMBL
Tradestie Score 39.8/100 38.4/100 NAMI
Profit Margin -23.9% -58.0% NAMI
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED BMBL

Relative Price Performance (Last 90 Days)

NAMI 1M: -6.6% · 3M: -42.5% BMBL 1M: +113.6% · 3M: +107.7%

Current Technical Phase

NAMI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.7%), weak momentum, RSI 42

RSI (14): 42.3 · Price: $1.85

BMBL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.6% over 20 days), RSI 90

RSI (14): 89.8 · Price: $5.96

Fundamentals Snapshot

Metric NAMI BMBL
Market Cap — —
Forward P/E 0.0 6.3
Trailing P/E 0.9 —
Revenue (TTM) — —
Revenue Growth -0.3% -0.2%
Gross Margin 0.1% 0.7%
Operating Margin -0.1% 0.3%
EPS 1.93 -4.15
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NAMI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.